Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Coffman

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Laboratory and Clinical Medicine|September 1, 1970
Skin blood flow in sclerodermaJ D Coffman
Postgraduate Medicine|August 1, 1985
Evaluation of the patient with Raynaud's phenomenonJ D Coffman
The New England Journal of Medicine|March 29, 1979
Drug therapy: vasodilator drugs in peripheral vascular diseaseJ D Coffman
Circulation|March 1, 1994
Enhanced cholinergic cutaneous vasodilation in Raynaud's phenomenonF Khan, J D Coffman
European Journal of Clinical Investigation|June 1, 1988
Role of alpha-adrenoceptor subtypes mediating sympathetic vasoconstriction in human digitsJ D Coffman, R A Cohen
Clinical Pharmacology and Therapeutics|May 1, 1987
Intra-arterial vasodilator agents to reverse human finger vasoconstrictionJ D Coffman, R A Cohen
Archives of Internal Medicine|January 1, 1979
Pathophysiology of Raynaud's diseaseJ L Halperin, J D Coffman
Atherosclerosis|January 1, 1983
The peripheral circulation and treatment of hyperlipoproteinemiasJ D Coffman, H M Rasmussen
Heart Disease (Hagerstown, Md.)|December 1, 2001
Drug treatment of peripheral vascular diseaseR T Eberhardt, J D Coffman
Clinical Pharmacology and Therapeutics|September 1, 1984
Effect of thromboxane synthetase inhibition in Raynaud's phenomenonJ D Coffman, H M Rasmussen
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Laboratory and Clinical Medicine|September 1, 1970
Skin blood flow in sclerodermaJ D Coffman
Postgraduate Medicine|August 1, 1985
Evaluation of the patient with Raynaud's phenomenonJ D Coffman
The New England Journal of Medicine|March 29, 1979
Drug therapy: vasodilator drugs in peripheral vascular diseaseJ D Coffman
Circulation|March 1, 1994
Enhanced cholinergic cutaneous vasodilation in Raynaud's phenomenonF Khan, J D Coffman
European Journal of Clinical Investigation|June 1, 1988
Role of alpha-adrenoceptor subtypes mediating sympathetic vasoconstriction in human digitsJ D Coffman, R A Cohen
Clinical Pharmacology and Therapeutics|May 1, 1987
Intra-arterial vasodilator agents to reverse human finger vasoconstrictionJ D Coffman, R A Cohen
Archives of Internal Medicine|January 1, 1979
Pathophysiology of Raynaud's diseaseJ L Halperin, J D Coffman
Atherosclerosis|January 1, 1983
The peripheral circulation and treatment of hyperlipoproteinemiasJ D Coffman, H M Rasmussen
Heart Disease (Hagerstown, Md.)|December 1, 2001
Drug treatment of peripheral vascular diseaseR T Eberhardt, J D Coffman
Clinical Pharmacology and Therapeutics|September 1, 1984
Effect of thromboxane synthetase inhibition in Raynaud's phenomenonJ D Coffman, H M Rasmussen
Pageof 6